FDA Adds Black Box Warning to Intercept’s Liver Disease Medicine

Drug Industry Daily
A A
The FDA issued a black box warning for Ocaliva (obeticholic acid), a liver disease medication that was incorrectly dosed as daily instead of weekly for patients with primary biliary cholangitis (PBC), increasing the risk of serious liver injury and worsening liver problems.

To View This Article:

Login

Subscribe To Drug Industry Daily